HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hybrid L1/2  + 2 method for gene selection in the Cox proportional hazards model.

AbstractBACKGROUND AND OBJECTIVE:
An important issue in genomic research is to identify the significant genes that related to survival from tens of thousands of genes. Although Cox proportional hazards model is a conventional survival analysis method, it does not induce the gene selection.
METHODS:
In this paper, we extend the hybrid L1/2  + 2 regularization (HLR) idea to the censored survival situation, a new edition of sparse Cox model based on the HLR method has been proposed. We develop two algorithms for solving the HLR penalized Cox model; one is the coordinate descent algorithm with HLR thresholding operator, the other is the weight iteration method.
RESULTS:
The proposed method was tested on six public mRNA data sets of serval kinds of cancers, AML, Breast cancer, Pancreatic cancer, DLBCL and Melanoma. The test results indicate that the method identified a small subset of genes but essential while giving best or equivalent predictive performance, as compared to some popular methods.
CONCLUSIONS:
The results of empirical and simulations imply that the proposed strategy is highly competitive in studying high dimensional survival data among several state-of-the-art methods.
AuthorsHai-Hui Huang, Yong Liang
JournalComputer methods and programs in biomedicine (Comput Methods Programs Biomed) Vol. 164 Pg. 65-73 (Oct 2018) ISSN: 1872-7565 [Electronic] Ireland
PMID30195432 (Publication Type: Journal Article)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • Genetic Markers
  • RNA, Messenger
Topics
  • Algorithms
  • Breast Neoplasms (genetics)
  • Computer Simulation
  • Databases, Genetic
  • Female
  • Gene Expression Profiling (statistics & numerical data)
  • Genetic Markers
  • Genomics (methods, statistics & numerical data)
  • Humans
  • Male
  • Models, Genetic
  • Neoplasms (genetics)
  • Proportional Hazards Models
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: